Published studies have corroborated the role of RAGE in the development of diabetes-associated renal diseases; for example, inhibition of RAGE through pharmacological antagonism or gene deletion showed significant improvements in the pathological features of diabetic nephropathy in animal models (Wendt et al., 2003; Reiniger et al., 2010). The gene discussed is AGER; the disease is diabetic kidney disease.